These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35803208)

  • 21. Expression analysis of cell cycle related lncRNAs in breast cancer tissues.
    Hussen BM; Taheri M; Behzad Moghadam K; Gholipour M; Eslami S; Nicknam A; Hidayat HJ; Ghafouri-Fard S; Ashrafi Hafez A
    Pathol Res Pract; 2023 May; 245():154453. PubMed ID: 37060825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclin D1 overexpression in invasive breast cancers: correlation with cyclin-dependent kinase 4 and oestrogen receptor overexpression, and lack of correlation with mitotic activity.
    Takano Y; Takenaka H; Kato Y; Masuda M; Mikami T; Saegusa M; Okayasu I
    J Cancer Res Clin Oncol; 1999; 125(8-9):505-12. PubMed ID: 10480344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression profiling revealed up-regulation of three lncRNAs in breast cancer samples.
    Mohebi M; Sattari A; Ghafouri-Fard S; Modarressi MH; Kholghi-Oskooei V; Taheri M
    Exp Mol Pathol; 2020 Dec; 117():104544. PubMed ID: 32976818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of the long noncoding RNAs DSCAM-AS1 and MANCR is a potential diagnostic marker for breast carcinoma.
    Tahmouresi F; Razmara E; Pakravan K; Mossahebi-Mohammadi M; Rouhollah F; Montazeri M; Sarrafzadeh A; Fahimi H; Babashah S
    Biotechnol Appl Biochem; 2021 Dec; 68(6):1250-1256. PubMed ID: 33012018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
    Xiao B; Zhang W; Chen L; Hang J; Wang L; Zhang R; Liao Y; Chen J; Ma Q; Sun Z; Li L
    Gene; 2018 Jun; 658():28-35. PubMed ID: 29518546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression analysis of AFAP1-AS1 and AFAP1 in breast cancer.
    Dianatpour A; Faramarzi S; Geranpayeh L; Mirfakhraie R; Motevaseli E; Ghafouri-Fard S
    Cancer Biomark; 2018; 22(1):49-54. PubMed ID: 29439313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression Analysis of Long Non-Coding RNAs Related With FOXM1, GATA3, FOXA1 and ESR1 in Breast Tissues.
    Hassani B; Taheri M; Asgari Y; Zekri A; Sattari A; Ghafouri-Fard S; Pouresmaeili F
    Front Oncol; 2021; 11():671418. PubMed ID: 34094972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression of indoleamine and tryptophan dioxygenases and three long non-coding RNAs in breast cancer.
    Ghafouri-Fard S; Taherian-Esfahani Z; Dashti S; Kholghi Oskooei V; Taheri M; Samsami M
    Exp Mol Pathol; 2020 Jun; 114():104415. PubMed ID: 32165090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opposite trends of GAS6 and GAS6-AS expressions in breast cancer tissues.
    Lavasani A; Hussen BM; Taheri F; Sattari A; Yousefi H; Omrani MD; Nazer N; Ghafouri-Fard S; Taheri M
    Exp Mol Pathol; 2021 Feb; 118():104600. PubMed ID: 33359886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
    Mrhalová M; Kodet R; Strnad P
    Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long Noncoding RNA HOXD-AS1 Promotes the Proliferation, Migration, and Invasion of Colorectal Cancer via the miR-526b-3p/CCND1 Axis.
    Yan F; Ma Y; Liu L; Li L; Deng J; Sun J
    J Surg Res; 2020 Nov; 255():525-535. PubMed ID: 32640404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA myocardial infarction associated transcript promotes the proliferation of cholangiocarcinoma cells by targeting miR-551b-3p/CCND1 axis.
    Chang W; Wang Y; Li W; Geng Z
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1067-1075. PubMed ID: 32064660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
    Zhou Q; Zhang W; Wang Z; Liu S
    BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of Treg-associated lncRNAs in breast cancer.
    Moallemi-Rad L; Ghorbani A; Dadyar M; Hussen BM; Rasul MF; Eslami S; Taheri M; Jamali E; Ghafouri-Fard S
    Pathol Res Pract; 2023 Jan; 241():154270. PubMed ID: 36535227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of SGO1 and SGO1-AS1 contribution in breast cancer.
    Nasim N; Ghafouri-Fard S; Soleimani S; Esfandi F; Shirkhoda M; Safaei M; Oskooei VK; Taheri M; Raheb J
    Hum Antibodies; 2019; 27(4):279-284. PubMed ID: 31156154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional CCND1 expression as a predictor of poor response to neoadjuvant chemotherapy with trastuzumab in HER2-positive/ER-positive breast cancer.
    Tanioka M; Sakai K; Sudo T; Sakuma T; Kajimoto K; Hirokaga K; Takao S; Negoro S; Minami H; Nakagawa K; Nishio K
    Breast Cancer Res Treat; 2014 Oct; 147(3):513-25. PubMed ID: 25200445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA (lncRNA) DSCAM-AS1 is upregulated in breast cancer.
    Tarighi M; Khalaj-Kondori M; Hosseinzadeh A; Abtin M
    Breast Dis; 2021; 40(2):63-68. PubMed ID: 33554879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening of a Novel Upregulated lncRNA, A2M-AS1, That Promotes Invasion and Migration and Signifies Poor Prognosis in Breast Cancer.
    Fang K; Caixia H; Xiufen Z; Zijian G; Li L
    Biomed Res Int; 2020; 2020():9747826. PubMed ID: 32352014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.
    Eeckhoute J; Carroll JS; Geistlinger TR; Torres-Arzayus MI; Brown M
    Genes Dev; 2006 Sep; 20(18):2513-26. PubMed ID: 16980581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway.
    Zhang M; Wang Y; Jiang L; Song X; Zheng A; Gao H; Wei M; Zhao L
    J Exp Clin Cancer Res; 2021 Jan; 40(1):41. PubMed ID: 33494806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.